跳至主要内容
临床试验/NCT06618365
NCT06618365进行中(未招募)不适用

Oral or Intra Muscular Vitamin D2 Vs Oral or Intra Muscular Vitamin D3 in Treatment of Vitamin D Deficiency.

Hamad Medical Corporation1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2023年2月2日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
100
试验地点
1
主要终点
Is oral Vitamin D3 superior to I.M Vitamin D2 in treating vitamin D deficiency?

研究概览

简要总结

The main purpose of this research is to find out if there is any difference between treating vitamin D deficiency with oral vitamin D3 or I.M vitamin D2. The second aim of this research is to confirm the superiority of Vitamin D3 over Vitamin D2 in treating vitamin D deficiency. Additional useful information in this research is to find out the best recommended maintenance dose of vitamin D and formula by having regular follow up of treated individuals once their serum vitamin D level reach the recommended normal serum level.

详细描述

In a systemic review, it was found that treating individuals who have vitamin D deficiency with vitamin D3 rather than vitamin D2 would be a better option. Vitamin D3 is superior in treating Vitamin D deficiency according to this systemic review. However, this systemic review raised a question of comparing oral to I.M treatment of vitamin D deficiency and no Data was available to support either treatment above the other.

The main purpose of this research is to find out if there is any difference between treating vitamin D deficiency with oral vitamin D3 or I.M vitamin D2. The second aim of this research is to confirm the superiority of Vitamin D3 over Vitamin D2 in treating vitamin D deficiency. Additional useful information in this research is to find out the best recommended maintenance dose of vitamin D and formula by having regular follow up of treated individuals once their serum vitamin D level reach the recommended normal serum level.

The research will involve 100 patients between the age of 20-50 years old. They will be divided into 4 groups. Each group will have either oral or I.M vitamin D2 or oral or I.M vitamin D3. The oral doses will be 50000 international units to be taken weekly and the I.M doses will be of 300000 international units which will be taken once every 6 weeks. Vitamin D level will be checked once every 4 weeks. The initial expected duration of the first phase of the research will be about 6-12 weeks which will give us a good orientation to answer the main and the second questions. Then the follow up may take up to another 6 months to check the maintenance dose of the best recommended oral or I.M treatment of bolus doses in certain intervals as initial trial.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
20 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age 20-50 years
  • Basal Vit D level should be between 10-18 ng/ml for phase 1 and between 30-50 ng/ml for phase 2

排除标准

  • Pregnant Women
  • history of renal implant or renal impairment of eGFR less than 60%
  • Abnormal Liver function test
  • patients with inflammatory bowel disease or of history of bariatric surgery

研究组 & 干预措施

Group 1: Vitamin D2 50000 units per tablet

Experimental

They will take one tablet weekly.

干预措施: Vitamin D Deficiency (Drug)

Group 2: Vitamin D2 300000 units Intramuscular injection

Experimental

They will have one injection every 6 weeks initially.

干预措施: Vitamin D Deficiency (Drug)

Group 3: Vitamin D3 50000 units tablet

Experimental

They will take one tablet weekly.

干预措施: Vitamin D Deficiency (Drug)

Group 4: Vitamin D3 300000 units Intramuscular injection

Experimental

They will have one injection every 6 weeks initially.

干预措施: Vitamin D Deficiency (Drug)

结局指标

主要结局

Is oral Vitamin D3 superior to I.M Vitamin D2 in treating vitamin D deficiency?

时间窗: 3 months from the administration of first dose

The primary outcome will be evaluated after 3 months from administration of the first dose for each subject to assess the serum level of vitamin D is attained. If a subject has reached normal Vitamin D serum level, they are qualified for phase 2 of the study.

次要结局

  • Confirming superiority of oral Vitamin D3 over oral Vitamin D2(3 months after administration of the first dose.)
  • to compare the treatment of vitamin D deficiency by using intramuscular injection of vitamin D3 or Vitamin D2(3 months after administration of the first dose.)

研究者

申办方类型
Industry
责任方
Principal Investigator
主要研究者

Dr Hassan Saqr

Senior Consultant

Hamad Medical Corporation

研究点 (1)

Loading locations...

相似试验